Axogen Inc

Axogen insider trading: Johnson John’s May 7, 2026 buy‑sell of 11,050 shares shows routine portfolio rebalancing, confirming insider confidence in the biotech’s valuation.

Axogen insider CFO buys 10,796 shares, signaling optimism amid a negative earnings backdrop and high‑variance market; see why this bullish move matters.